Skip to main content
SpringerLink
Log in

Molecular Profile and Clinicopathologic Features of Follicular Variant Papillary Thyroid Carcinoma

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

The non-invasive encapsulated follicular variant of papillary thyroid carcinoma (FVPTC) has an indolent clinical behavior. Recently, it was proposed that this tumor type should be reclassified as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). To characterize NIFTPs, we evaluated the molecular and clinicopathologic characteristics of each FVPTC subtype. This study enrolled 29 patients with FVPTC who underwent thyroidectomy between January 2007 and June 2017. They were classified as non-invasive encapsulated FVPTC (NIFTP, n = 10), invasive encapsulated FVPTC (n = 11), and infiltrative FVPTC (n = 8) by two independent pathologists. Genetic alterations were analyzed by targeted next-generation sequencing using formalin-fixed, paraffin-embedded tissue samples and the clinicopathologic characteristics were retrospectively reviewed. There was no difference in preoperative cytologic classification between NIFTPs and invasive encapsulated FVPTCs, whereas infiltrative FVPTC was more likely to be Bethesda class VI than the encapsulated type (50% versus 9.5%; P = 0.033). Lymph node metastasis was not found in NIFTPs. There was no BRAFV600E mutation in NIFTPs, whereas one of 11 invasive encapsulated FVPTCs and three of 8 infiltrative FVPTCs harbored BRAFV600E. RAS mutations were frequently detected in encapsulated FVPTCs (5 of 10 NIFTPs and 4 of 11 invasive encapsulated FVPTCs) but were only detected in one case of the infiltrative type. There were no differences in molecular or clinicopathologic profiles between non-invasive and invasive encapsulated FVPTCs, except for lymph node metastasis and the presence of BRAFV600E. NIFTP has favorable pathologic characteristics with a high frequency of RAS mutations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. JKC C (2000) Tumors of the thyroid and parathyroid glands.: Churchill Livingstone

  2. Lam AK, Lo CY, Lam KS (2005) Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr Pathol 16(4):323–330

    PubMed  Google Scholar 

  3. Tielens ET, Sherman SI, Hruban RH, Ladenson PW (1994) Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer. 73(2):424–431

    CAS  PubMed  Google Scholar 

  4. Passler C, Prager G, Scheuba C et al (2003) Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 138(12):1362–1366

    PubMed  Google Scholar 

  5. S. L. (1960) Carcinoma of the thyroid gland: Aclinical and pathologic study of 293 patients at the University of California hospital

  6. Chan J (2002) Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 117(1):16–18

    PubMed  Google Scholar 

  7. Liu J, Singh B, Tallini G et al (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 107(6):1255–1264

    PubMed  Google Scholar 

  8. Rivera M, Ricarte-Filho J, Knauf J et al (2010) Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol 23(9):1191–1200

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Vivero M, Kraft S, Barletta JA (2013) Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid. 23(3):273–279

    CAS  PubMed  Google Scholar 

  10. Bychkov A, Hirokawa M, Jung CK et al (2017) Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Thyroid. 27(7):983–984

    PubMed  Google Scholar 

  11. Finnerty BM, Kleiman DA, Scognamiglio T et al (2015) Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison. Ann Surg Oncol 22(4):1200–1206

    PubMed  Google Scholar 

  12. Piana S, Frasoldati A, Di Felice E, Gardini G, Tallini G, Rosai J (2010) Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol 34(6):868–872

    PubMed  Google Scholar 

  13. Nikiforov YE, Seethala RR, Tallini G et al (2016) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2(8):1023–1029

    PubMed  PubMed Central  Google Scholar 

  14. Howitt BE, Jia Y, Sholl LM, Barletta JA (2013) Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma. Thyroid. 23(10):1256–1262

    CAS  PubMed  Google Scholar 

  15. Kim TH, Lee M, Kwon AY et al (2018) Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma. Histopathology. 72(4):648–661

    PubMed  Google Scholar 

  16. Howitt BE, Paulson VA, Barletta JA (2015) Absence of BRAF V600E in non-infiltrative, non-invasive follicular variant of papillary thyroid carcinoma. Histopathology. 67(4):579–582

    PubMed  Google Scholar 

  17. Kim M, Jeon MJ, Oh HS et al (2018) BRAF and RAS mutational status in noninvasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea. Thyroid. 28(4):504–510

    CAS  PubMed  Google Scholar 

  18. Zhao L, Dias-Santagata D, Sadow PM, Faquin WC (2017) Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Cancer Cytopathol 125(5):323–331

    CAS  PubMed  Google Scholar 

  19. Cibas ES, Ali SZ (2009) The Bethesda system for reporting thyroid cytopathology. Thyroid. 19(11):1159–1165

    PubMed  Google Scholar 

  20. Li H, Durbin R (2009) Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 25(14):1754–1760

    CAS  PubMed  PubMed Central  Google Scholar 

  21. DePristo MA, Banks E, Poplin R et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491–498

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38(16):e164

    PubMed  PubMed Central  Google Scholar 

  23. Cingolani P, Platts A, Wang le L et al (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6(2):80–92

    CAS  Google Scholar 

  24. Landrum MJ, Lee JM, Benson M et al (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44(D1):D862–D868

    CAS  PubMed  Google Scholar 

  25. Wei Z, Wang W, Hu P, Lyon GJ, Hakonarson H (2011) SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data. Nucleic Acids Res 39(19):e132

    CAS  PubMed  PubMed Central  Google Scholar 

  26. McFadden DG, Dias-Santagata D, Sadow PM et al (2014) Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 99(11):E2457–E2462

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Kim MJ, Won JK, Jung KC et al (2018) Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma. Thyroid. 28(3):311–318

    CAS  PubMed  Google Scholar 

  28. Cho U, Mete O, Kim MH, Bae JS, Jung CK (2017) Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol 30(6):810–825

    CAS  PubMed  Google Scholar 

  29. Nikiforov YE, Baloch ZW, Hodak SP et al (2018) Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with Papillarylike nuclear features. JAMA Oncol 4(8):1125–1126

    PubMed  PubMed Central  Google Scholar 

  30. Trovisco V, Soares P, Soares R, Magalhaes J, Sa-Couto P, Sobrinho-Simoes M (2005) A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol 36(6):694–697

    CAS  PubMed  Google Scholar 

  31. Lee SR, Jung CK, Kim TE et al (2013) Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing. Thyroid. 23(11):1416–1422

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Jang MA, Lee ST, Oh YL et al (2012) Identification of a rare 3 bp BRAF gene deletion in a thyroid nodule by mutant enrichment with 3′-modified oligonucleotides polymerase chain reaction. Ann Lab Med 32(3):238–241

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Jung SH, Kim MS, Jung CK et al (2016) Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma. Oncotarget. 7(43):69638–69648

    PubMed  PubMed Central  Google Scholar 

  34. Nicolson NG, Murtha TD, Dong W et al (2018) Comprehensive genetic analysis of follicular thyroid carcinoma predicts prognosis independent of histology. J Clin Endocrinol Metab 103:2640–2650

    PubMed  Google Scholar 

  35. Nikiforova MN, Wald AI, Roy S, Durso MB, Nikiforov YE (2013) Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab 98(11):E1852–E1860

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Kunstman JW, Juhlin CC, Goh G et al (2015) Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum Mol Genet 24(8):2318–2329

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Guerra A, Sapio MR, Marotta V et al (2012) The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. J Clin Endocrinol Metab 97(2):517–524

    CAS  PubMed  Google Scholar 

  38. Ustun B, Chhieng D, Prasad ML et al (2014) Follicular variant of papillary thyroid carcinoma: accuracy of FNA diagnosis and implications for patient management. Endocr Pathol 25(3):257–264

    CAS  PubMed  Google Scholar 

  39. Paulson VA, Shivdasani P, Angell TE et al (2017) Noninvasive follicular thyroid neoplasm with papillary-like nuclear features accounts for more than half of "carcinomas" harboring RAS mutations. Thyroid. 27(4):506–511

    CAS  PubMed  Google Scholar 

  40. Shi X, Liu R, Basolo F et al (2016) Differential Clinicopathological risk and prognosis of major papillary thyroid Cancer variants. J Clin Endocrinol Metab 101(1):264–274

    CAS  PubMed  Google Scholar 

  41. Haugen BR, Sawka AM, Alexander EK et al (2017) American Thyroid Association guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 27(4):481–483

    CAS  PubMed  Google Scholar 

Download references

Funding

This study was funded by a grant from Myongji Hospital (grant number 16–03-03).

Author information

Author notes

  1. Seo Young Sohn and Jeong-Ju Lee contributed equally to this work.

Authors and Affiliations

  1. Department of Internal Medicine, Division of Endocrinology and Metabolism, Hanyang University College of Medicine, Myongji Hospital, Goyang, South Korea

    Seo Young Sohn & Jae Hyuk Lee

  2. Department of Pathology, Hanyang University College of Medicine, Myongji Hospital, Goyang, South Korea

    Jeong-Ju Lee

  3. Department of Pathology, Dongguk University Ilsan Hospital, Goyang, South Korea

    Jeong-Ju Lee

Authors
  1. Seo Young Sohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeong-Ju Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jae Hyuk Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seo Young Sohn.

Ethics declarations

Conflict of Interest

All authors have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 23 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sohn, S.Y., Lee, JJ. & Lee, J.H. Molecular Profile and Clinicopathologic Features of Follicular Variant Papillary Thyroid Carcinoma. Pathol. Oncol. Res. 26, 927–936 (2020). https://doi.org/10.1007/s12253-019-00639-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-019-00639-8

Keywords

Search

Navigation